Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Lifecore Biomedical $LFCR• NASDAQ | PharmaceuticalsPharmaceuticals | Greenhaven Road Capital - LFCR Another top-five holding is Lifecore (LFCR). The entire thesis... | BULL | View Pitch → | |
| Jan 27, 2026 | Fund Letter | Matthew SweeneyLaughing Water Capital | Lifecore Biomedical $LFCR• NASDAQ | PharmaceuticalsPharmaceuticals | Laughing Water Capital 2025 Q4 (LFCR) Take for example our investment in Lifecore Biomedical, our CDMO that puts injectable drugs into syringes and vials. I have written... | BULL | View Pitch → |
| Jan 8, 2026 | Fund Letter | Matthew SweeneyLaughing Water Capital | Lifecore Biomedical $LFCR• NASDAQ | PharmaceuticalsPharmaceuticals | Laughing Water Capital 2025 Q2 (LFCR) Lifecore Biomedical Inc. (LFCR) – Lifecore, our fill-finish CDMO, continues to work toward their dual goals of increasing capacity utilization and expanding margins. ” This belief... | BULL | View Pitch → |
| Dec 6, 2025 | Fund Letter | Lifecore Biomedical $LFCR• NASDAQ | PharmaceuticalsPharmaceuticals | Greenhaven Road Capital 2025 Q2 (LFCR) LifeCore is a contract drug manufacturer which has recently added significant manufacturing capacity. They are operating... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.